nanocovax
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Dec 10, 2020 (NCT04683484)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04922788 | Phase 3 | Jun 7, 2021 | Epoch Biosciences |
| NCT04683484 | Phase 1/Phase 2 (Phase 2) | Dec 10, 2020 | Epoch Biosciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Epoch Biosciences | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1